erythrosine has been researched along with hydralazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishback, DB | 1 |
| Chatard, M; Perek, N; Puech, C; Roche, F | 1 |
2 other study(ies) available for erythrosine and hydralazine
| Article | Year |
|---|---|
Fluorescein circulation time and the treatment of hypertension in the aged.
Topics: Adult; Age Factors; Aged; Blood Circulation Time; Blood Pressure; Carbamates; Ethacrynic Acid; Female; Fluoresceins; Furosemide; Glomerular Filtration Rate; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Methyldopa; Middle Aged; Potassium; Reserpine; Spironolactone | 1973 |
Hydralazine is a Suitable Mimetic Agent of Hypoxia to Study the Impact of Hypoxic Stress on In Vitro Blood-Brain Barrier Model.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Cell Hypoxia; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Cobalt; Coculture Techniques; Endothelial Cells; Fluorescein; Fluoresceins; Fluorescent Dyes; Gene Expression Regulation; Hydralazine; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Models, Biological; Neuroglia; Occludin; Permeability; Rats; Zonula Occludens-1 Protein | 2017 |